Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli, Emma Hudson, Yoland Antill, Chel Hun Choi, Manuela Rabaglio, Frederic Marmé, Christian Marth, Gabriella Parma, Lorena Fariñas-Madrid, Shin Nishio, Karen Allan, Yeh Chen Lee, Elisa Piovano, Beatriz Pardo, Satoshi Nakagawa, John McQueen, Claudio Zamagni, Luís Manso, Kazuhiro Takehara, Giulia Tasca, Annamaria Ferrero, Germana Tognon, Andrea Alberto Lissoni, Mariacristina Petrella, Maria Elena Laudani, Eliana Rulli, Sara Uggeri, M.P. Barretina Ginesta, Paolo Zola, Cláudia Casanova, Valentina Arcangeli, Lorenzo Antonuzzo, Angiolo Gadducci, Stefania Cosio, Andrew R. Clamp, Mojca Persic, Ian McNeish, Laura A. Tookman, Andrés Redondo Sanchez, Chel Hun Choi, Editta Baldini, Innocenza Palaia, Pierluigi Benedetti Panici, Nobutaka Takahashi, Janine Lombard, Antonio Ardizzoia, Alessandra Bologna, Ana Maria Herrero Ibáñez, Antonino Musolino, Raúl Márquez Vázquez, Klaus Pietzner, Elena Ioana Braicu, Viola Heinzelmann‐Schwarz, Melanie Powell, Yoshihito Yokoyama, Sally Baron‐Hay, Chiara Abeni, Cristina Martín Lorente, Juan Cueva, Fabian Trillsch, Florian Heitz, Beyhan Ataseven, Edgar Petru, MartinLeonhard Heubner, Azmat Sadozye, Sidharth Dubey, Andrea Tazbirkova, Susan Tiley, K. Chrystal, Sang Wun Kim, Mathias Fehr, Kate Scatchard, Anjana Anand, Alexandra A. Taylor, Hidemichi Watary, Takayuki Enomoto, Kosuke Yoshihara, Sudarsha Selva‐Nayagam, Bhaskar Karki, Michelle Harrison, Kate Wilkinson, Jeffrey C. Goh, Amanda Glasgow, Lorraine A. Chantrill, Chulmin Lee, A. Bertolini, Filomena Narducci, Giovanna Bellotti, Vittorio Fusco, Stefan Aebi, Maria Del Grande, Ilaria Colombo, Hideki Tokunaga, Shogo Shigeta, Geraldine Goss, Zhen R. Siow, Christopher Steer